Aspen Pharmacare investors eye CEO’s $1.2 million pay after weak results
Aspen investors head into December AGM after years of weak earnings and share losses, ready to question whether CEO pay still makes sense.
Stephen Saad
South African tycoon Stephen Saad’s Aspen wins $29 million settlement
Stephen Saad’s Aspen wins $29 million settlement in mRNA production dispute, boosting investor confidence after a tough fiscal year.